Early research (Phase 1)Study completedNCT00715182
What this trial is testing
A Phase I/II Study to Assess the Safety and Efficacy of TKI258 for the Treatment of Refractory Advanced/Metastatic Renal Cell Cancer
Who this might be right for
Advanced/ Metastatic Renal Cell Cancer
Novartis Pharmaceuticals 87